Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas

Name: Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas
License: Public Domain

Emory University

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

grade 1 follicular lymphoma, grade 2 follicular lymphoma, grade 3a follicular lymphoma, indolent non-hodgkin lymphoma, lymphoplasmacytic lymphoma, lymphoproliferative disorder

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 180408
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.